| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Approaches using molecular imaging technology — use of PET in clinical microdose studies
|
Wagner, Claudia C.
|
|
2011
|
63 |
7 |
p. 539-546
8 p.
|
artikel
|
| 2 |
Comparative requirements for exploratory clinical trials — eIND, eCTA and microdosing
|
Muller, Patrick Y.
|
|
2011
|
63 |
7 |
p. 511-517
7 p.
|
artikel
|
| 3 |
Editorial Board
|
|
|
2011
|
63 |
7 |
p. ii-
1 p.
|
artikel
|
| 4 |
Ethical, legal, and social implications (ELSI) of microdose clinical trials
|
Kurihara, Chieko
|
|
2011
|
63 |
7 |
p. 503-510
8 p.
|
artikel
|
| 5 |
Impact of microdosing clinical study — Why necessary and how useful?
|
Sugiyama, Yuichi
|
|
2011
|
63 |
7 |
p. 494-502
9 p.
|
artikel
|
| 6 |
Molecular imaging with SPECT as a tool for drug development
|
Gomes, Célia M.
|
|
2011
|
63 |
7 |
p. 547-554
8 p.
|
artikel
|
| 7 |
New strategy for drug development with exploratory IND studies: Scientific basis and future directions
|
Yamashita, Shinji
|
|
2011
|
63 |
7 |
p. 493-
1 p.
|
artikel
|
| 8 |
Novel strategies for microdose studies using non-radiolabeled compounds
|
Maeda, Kazuya
|
|
2011
|
63 |
7 |
p. 532-538
7 p.
|
artikel
|
| 9 |
Quantifying exploratory low dose compounds in humans with AMS
|
Dueker, Stephen R.
|
|
2011
|
63 |
7 |
p. 518-531
14 p.
|
artikel
|
Tijdschrift beschrijving